查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1638763

2024 - 2032 年医疗保健数据货币化市场机会、成长驱动因素、产业趋势分析与预测

Healthcare Data Monetization Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2024 - 2032
出版日期: | 出版商: Global Market Insights Inc. | 英文 140 Pages | 商品交期: 2-3个工作天内

价格
简介目录

全球医疗保健数据货币化市场到2023 年价值为5.162 亿美元，预计2024 年至2032 年复合年增长率为17.1%。资料的。

在货币化方式方面，市场资料直接货币化和间接货币化，其中直接货币化在 2023 年产生的收入最高为 3.53 亿美元。三方许可或出售资料。该模型支援即时收入流，并透过订阅、授权交易和按访问付费模式满足对高品质健康洞察的需求，提供对基本医疗保健资料的即时存取。

市场进一步按资料类型分为几类，包括临床资料、索赔资料、EHR资料和基因组资料。 2023年，临床资料以35%的市占率领先。此类别包括全面的患者记录、诊断结果和治疗历史，为医疗服务提供者和研究人员提供了重要的见解。製药公司利用临床资料来加强药物开发、完善临床试验并加速监管审批，支持精准医疗和个人化治疗的创新。

市场范围
开始年份 2023年
预测年份 2024-2032
起始值 5.162 亿美元
预测值 21亿美元
复合年增长率 17.1%

北美在医疗保健资料货币化市场上处于领先地位，2023 年收入为2.356 亿美元，预计到2032 年将以16.6% 的复合年增长率增长。投资使其成为领跑者。在美国，由医院、卫生系统和研究机构组成的庞大网路产生了大量的医疗保健资料，製药公司、保险公司和医疗保健提供者利用这些数据来改善患者的治疗效果并简化营运。

目录

第 1 章：方法与范围

第 2 章：执行摘要

第 3 章：产业洞察

  • 产业生态系统分析
  • 产业影响力
    • 成长动力
      • 更多采用数位健康解决方案
      • 决策中对资料的需求不断增长
      • 资料分析的技术进步
    • 产业陷阱与挑战
      • 资料隐私和安全问题
  • 成长潜力分析
  • 监管环境
  • 未来市场趋势
  • 技术景观
  • 波特的分析
  • 差距分析
  • 道德和隐私考虑
  • PESTEL分析

第 4 章：竞争格局

  • 介绍
  • 公司矩阵分析
  • 主要市场参与者的竞争分析
  • 竞争定位矩阵
  • 战略仪表板

第 5 章：市场估计与预测：按货币化类型，2021 - 2032

  • 主要趋势
  • 直接货币化
    • 数据作为产品
    • 数据即服务
  • 间接货币化
    • 分析和洞察服务
    • 广告和定向行销

第 6 章：市场估计与预测：按资料类型，2021 - 2032

  • 主要趋势
  • 临床资料
  • 索赔资料
  • 电子病历资料
  • 基因组资料
  • 其他资料类型

第 7 章：市场估计与预测：按应用分类，2021 - 2032

  • 主要趋势
  • 预测分析与疾病管理
  • 人口健康管理
  • 收入周期管理
  • 精准医疗
  • 其他应用

第 8 章：市场估计与预测：按最终用途，2021 - 2032 年

  • 主要趋势
  • 製药和生物技术公司
  • 付款人和保险提供者
  • 医疗保健提供者
  • 研究机构和学术组织
  • 其他最终用户

第 9 章：市场估计与预测：按地区，2021 - 2032

  • 主要趋势
  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 荷兰
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋

第 10 章：公司简介

  • Accenture
  • Change Healthcare
  • H1
  • IBM
  • Infor
  • Innovaccer
  • LexisNexis Risk Solutions
  • McKesson Medical-Surgical
  • Open Text Corporation
  • Optum
  • Oracle
  • SAS Institute
简介目录
Product Code: 12159

The Global Healthcare Data Monetization Market, valued at USD 516.2 million in 2023, is forecasted to grow at a CAGR of 17.1% from 2024 to 2032. The rapid expansion is driven by a rising adoption of digital health technologies, an increasing demand for data-driven decision-making, and advancements in data analytics.

In terms of monetization approach, the market is segmented into direct and indirect monetization, with direct monetization generating the highest revenue of USD 353 million in 2023. Direct monetization allows healthcare providers, data organizations, and other entities to license or sell data directly to third-party buyers, such as pharmaceutical companies, insurers, and research bodies. This model supports immediate revenue streams and addresses the demand for high-quality health insights through subscriptions, licensing deals, and pay-per-access models, providing real-time access to essential healthcare data.

The market is further divided by data type into categories, including clinical data, claims data, EHR data, and genomic data. In 2023, clinical data led with a 35% market share. This category, which includes comprehensive patient records, diagnostic results, and treatment histories, offers critical insights for health providers and researchers. Pharmaceutical companies utilize clinical data to enhance drug development, refine clinical trials, and accelerate regulatory approvals, supporting innovations in precision medicine and personalized treatment.

Market Scope
Start Year2023
Forecast Year2024-2032
Start Value$516.2 Million
Forecast Value$2.1 Billion
CAGR17.1%

North America led the healthcare data monetization market with revenues of USD 235.6 million in 2023, projected to grow at a 16.6% CAGR through 2032. North America's advanced digital health infrastructure and significant investment in healthcare IT make it a frontrunner. In the U.S., a vast network of hospitals, health systems, and research institutions generates extensive healthcare data utilized by pharmaceutical companies, insurers, and healthcare providers to enhance patient outcomes and streamline operations.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates & calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increased adoption of digital health solutions
      • 3.2.1.2 Rising demand for data in decision making
      • 3.2.1.3 Technological advancements in data analysis
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 Data privacy and security concerns
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 Future market trends
  • 3.6 Technology landscape
  • 3.7 Porter's analysis
  • 3.8 GAP analysis
  • 3.9 Ethical and privacy considerations
  • 3.10 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Competitive analysis of major market players
  • 4.4 Competitive positioning matrix
  • 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Monetization Type, 2021 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Direct monetization
    • 5.2.1 Data as a product
    • 5.2.2 Data as a service
  • 5.3 Indirect monetization
    • 5.3.1 Analytics and insight services
    • 5.3.2 Advertising and targeted marketing

Chapter 6 Market Estimates and Forecast, By Data Type, 2021 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Clinical data
  • 6.3 Claims data
  • 6.4 EHR data
  • 6.5 Genomic data
  • 6.6 Other data types

Chapter 7 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Predictive analytics and disease management
  • 7.3 Population health management
  • 7.4 Revenue cycle management
  • 7.5 Precision medicine
  • 7.6 Other applications

Chapter 8 Market Estimates and Forecast, By End Use, 2021 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 Pharmaceutical and biotech companies
  • 8.3 Payers and insurance providers
  • 8.4 Healthcare providers
  • 8.5 Research institutes and academic organizations
  • 8.6 Other end users

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

  • 9.1 Key trends
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Spain
    • 9.3.5 Italy
    • 9.3.6 Netherlands
  • 9.4 Asia Pacific
    • 9.4.1 China
    • 9.4.2 Japan
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 South Korea
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Argentina
  • 9.6 Middle East and Africa
    • 9.6.1 South Africa
    • 9.6.2 Saudi Arabia
    • 9.6.3 UAE

Chapter 10 Company Profiles

  • 10.1 Accenture
  • 10.2 Change Healthcare
  • 10.3 H1
  • 10.4 IBM
  • 10.5 Infor
  • 10.6 Innovaccer
  • 10.7 LexisNexis Risk Solutions
  • 10.8 McKesson Medical-Surgical
  • 10.9 Open Text Corporation
  • 10.10 Optum
  • 10.11 Oracle
  • 10.12 SAS Institute